does semaglutide cause naion 🇺🇸, A 2025 systematic review and meta-analysis published in Ophthalmology stratified evidence by indication and study design. In diabetes cohorts, observational data showed a higher hazard with GLP-1 medicine and non-arteritic anterior

However, they rarely turn a true GLP-1 non-responder into someone who loses a significant amount of weight

Semaglutide typically reduces bloating by lowering food volume and gas production in the digestive tract

American Society of Anesthesiologists+1 In late 20242025 , multi-specialty guidance and larger studies began to suggest that most patients can safely continue GLP-1 medications , especially if they are stable on a long-term dose

Ik maak beelden die je verhaal vertellen.

[17] [18] Whilst GLP-1 medications are not currently licensed specifically for PCOS treatment in the UK, they may be prescribed for weight management or type 2 diabetes in women who also have PCOS